{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:27Z","timestamp":1786982667270,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13555-024-01306-w","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T14:04:05Z","timestamp":1732197845000},"page":"3379-3393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics of Patients with Generalized Pustular Psoriasis: A Report of the Polish Generalized Pustular Psoriasis Group"],"prefix":"10.1007","volume":"14","author":[{"given":"Marta","family":"Ko\u0142t-Kami\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Marek-J\u00f3zefowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Nowowiejska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Siekierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Duchnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"J\u00f3\u017awicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kiedrowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Mleczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Arasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kucharczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Walecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lesiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Narbutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Marchlewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Owczarczyk-Saczonek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Kr\u0119cisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-1754","authenticated-orcid":false,"given":"Adam","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"1306_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-021-00652-1","volume":"23","author":"H Fujita","year":"2022","unstructured":"Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23:31\u20138.","journal-title":"Am J Clin Dermatol"},{"key":"1306_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13555-022-00881-0","volume":"13","author":"R Rivera-D\u00edaz","year":"2023","unstructured":"Rivera-D\u00edaz R, Daud\u00e9n E, Carrascosa JM, et al. Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment. Dermatol Ther (Heidelb). 2023;13:673\u201388.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1306_CR3","first-page":"669","volume":"16","author":"F Augey","year":"2006","unstructured":"Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16:669\u201373.","journal-title":"Eur J Dermatol"},{"key":"1306_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/jdv.18851","volume":"37","author":"L Puig","year":"2023","unstructured":"Puig L, Choon SE, Gottlieb AB, et al. Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol. 2023;37:737\u201352.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1306_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40257-021-00664-x","volume":"23","author":"M Zheng","year":"2022","unstructured":"Zheng M, Jullien D, Eyerich K. The prevalence and disease characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23:5\u201312.","journal-title":"Am J Clin Dermatol"},{"key":"1306_CR6","first-page":"753","volume":"20","author":"K Reich","year":"2022","unstructured":"Reich K, Augustin M, Gerdes S, et al. Generalized pustular psoriasis: overview of the status quo and results of a panel discussion. J Dtsch Dermatol Ges. 2022;20:753\u201371.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1306_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/1744666X.2022.2116003","volume":"18","author":"H Bachelez","year":"2022","unstructured":"Bachelez H, Barker J, Burden AD, et al. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol. 2022;18:1033\u201347.","journal-title":"Expert Rev Clin Immunol"},{"key":"1306_CR8","doi-asserted-by":"crossref","unstructured":"Wolf P, Ceovic R, Conrad C, et al. Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network. J Eur Acad Dermatol Venereol. 2024.","DOI":"10.1111\/jdv.19808"},{"key":"1306_CR9","doi-asserted-by":"crossref","unstructured":"Choon SE, van de Kerkhof P, Gudjonsson JE, et al. International consensus definition and diagnostic criteria for generalized pustular psoriasis from the International Psoriasis Council. JAMA Dermatol. 2024.","DOI":"10.1001\/jamadermatol.2024.0915"},{"key":"1306_CR10","doi-asserted-by":"crossref","unstructured":"Bellinato F, Gisondi P, Marzano AV, et al. Characteristics of patients experiencing a flare of generalized pustular psoriasis: a multicenter observational study. Vaccines (Basel). 2023;11.","DOI":"10.3390\/vaccines11040740"},{"key":"1306_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/1346-8138.16164","volume":"48","author":"T Tosukhowong","year":"2021","unstructured":"Tosukhowong T, Kiratikanon S, Wonglamsam P, et al. Epidemiology and clinical features of pustular psoriasis: a 15-year retrospective cohort. J Dermatol. 2021;48:1931\u20135.","journal-title":"J Dermatol"},{"key":"1306_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","volume":"143","author":"S Twelves","year":"2019","unstructured":"Twelves S, Mostafa A, Dand N, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143:1021\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"1306_CR13","doi-asserted-by":"crossref","unstructured":"Adachi A, Honda T. Regulatory roles of estrogens in psoriasis. J Clin Med. 2022;11.","DOI":"10.3390\/jcm11164890"},{"key":"1306_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","volume":"385","author":"MJ Prince","year":"2015","unstructured":"Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385:549\u201362.","journal-title":"Lancet"},{"key":"1306_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu JJ, Kavanaugh A, Lebwohl MG, et al. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2022;36:797\u2013806.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1306_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2022.09.049","volume":"88","author":"S L\u00f6fvendahl","year":"2023","unstructured":"L\u00f6fvendahl S, Norlin JM, Schmitt-Egenolf M. Comorbidities in patients with generalized pustular psoriasis: a nationwide population-based register study. J Am Acad Dermatol. 2023;88:736\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1306_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.25251\/skin.7.supp.246","volume":"7","author":"D Jullien","year":"2023","unstructured":"Jullien D, Azura ALM. Flare frequency and duration in patients with generalized pustular psoriasis (GPP). SKIN J Cutan Med. 2023;7:246.","journal-title":"SKIN J Cutan Med."},{"key":"1306_CR18","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jaad.2021.06.008","volume":"86","author":"H Miyachi","year":"2022","unstructured":"Miyachi H, Konishi T, Kumazawa R, et al. Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol. 2022;86:1266\u201374.","journal-title":"J Am Acad Dermatol"},{"key":"1306_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40257-021-00654-z","volume":"23","author":"SE Choon","year":"2022","unstructured":"Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23:21\u20139.","journal-title":"Am J Clin Dermatol"},{"key":"1306_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/exd.14766","volume":"32","author":"LY Lim","year":"2023","unstructured":"Lim LY, Oon HH. Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis. Exp Dermatol. 2023;32:1246\u201352.","journal-title":"Exp Dermatol"},{"key":"1306_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13555-021-00493-0","volume":"11","author":"B Strober","year":"2021","unstructured":"Strober B, Kotowsky N, Medeiros R, et al. Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a Survey of Corrona Registry Dermatologists. Dermatol Ther (Heidelb). 2021;11:529\u201341.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1306_CR22","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","volume":"133","author":"K Sugiura","year":"2013","unstructured":"Sugiura K, Takemoto A, Yamaguchi M, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Investig Dermatol. 2013;133:2514\u201321.","journal-title":"J Investig Dermatol"},{"key":"1306_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/1346-8138.16949","volume":"50","author":"K Hayama","year":"2023","unstructured":"Hayama K, Iwasaki R, Tian Y, et al. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study. J Dermatol. 2023;50:1531\u20138.","journal-title":"J Dermatol"},{"key":"1306_CR24","doi-asserted-by":"crossref","unstructured":"Avallone G, Maronese CA, Murgia G, Carrera CG, Mastorino L, Roccuzzo G, Dapavo P, Alberti-Violetti S, Quaglino P, Ribero S, Marzano AV. Interleukin-17 vs. interleukin-23 inhibitors in pustular and erythrodermic psoriasis: a retrospective, multicentre cohort study. J Clin Med 2023;12:1662.","DOI":"10.3390\/jcm12041662"},{"issue":"10412","key":"1306_CR25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(23)01378-8","volume":"402","author":"A Morita","year":"2023","unstructured":"Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Tha\u00e7i D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial. Lancet. 2023;402(10412):1541\u201351.","journal-title":"Lancet"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01306-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T23:49:36Z","timestamp":1732837776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01306-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01306-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marta Ko\u0142t-Kami\u0144ska has served as a subinvestigator in clinical studies for Almirall, AnaptysBio, Bristol Myers Squibb, Celltrion, Galderma, Kiniksa, and Novartis. Irena Walecka has served as an investigator or participated in advisory boards and has received honoraria from AbbVie, Almirall, Boehringer Ingelheim, Eli Lilly, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Polfa, Sanofi, Sandoz, and UCB Pharma. Jacek C Szepietowski has received consulting fees or honoraria from Galderma, AbbVie, Almirall, Eli Lilly, Janssen, LEO Pharma, Novartis, Pierre-Fabre, Pfizer, Sanofi-Genzyme, Trevi, and UCB; and has served as an investigator for AbbVie, Amgen, Bristol Myers Squibb, Galapagos, Galderma, Incyte, InflaRx, Janssen, Kliniksa, Kymab, Menlo Therapeutics, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Trevi Therapeutics, and UCB Pharma. Jacek C Szepietowski is an Editorial Board member of Dermatology and Therapy and he was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Aleksandra Lesiak has served as an investigator or participated in advisory boards for Abbvie, Almirall, AnaptysBio, Boehringer Ingelheim,Dermira, Galderma, Janssen,, LEO Pharma, Novartis, Pierre Fabre, Pfizer, and has received honoraria from Boehringer Ingelheim, Sanofi, Eli Lilly, LEO Pharma, Novartis, Sandoz, Astra Zeneca, Abbvie, Almirall, Alfasigma, UCB. Joanna Narbutt has served as an investigator or participated in advisory boards for AbbVie, Almirall,, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Dermira, Galderma, Inflarx, Janssen, Kymab, LEO Pharma, Novartis, Pierre Fabre, Pfizer, Eli Lilly, Novartis, Sandoz, Samsung, Takeda and UCB; Agnieszka Owczarczyk-Saczonek has served as an investigator or participated in advisory boards and has received honoraria from AbbVie, Allergan, Almirall, Amgen, Boehringer Ingelheim, Celltrion, Eli Lilly, Galderma, Janssen, LEO Pharma, Novartis, Pfizer, Pierre-Fabre, Sanofi, Sandoz, and UCB Pharma. Dorota Krasowska has served as an investigator or participated in advisory boards for AbbVie, Almirall, Amgen, Boehringer Ingelheim, Celltrion, Dermira, Eli Lilly, Galderma, Galapagos, Inocyte, LEO Pharma, Novartis, Pfizer, and has received honoraria from Abbvie, Boehringer Ingelheim, Eli Lilly, Novartis, Pfizer. Adam Reich has served as an investigator or participated in advisory boards for AbbVie, Almirall, Alvotech, Amgen, AnaptysBio, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Dermira, Galderma, Inflarx, Janssen, Kiniksa, Kymab, LEO Pharma, Novartis, Pierre Fabre, Pfizer, Trevi Therapeutics, and UCB; and has received honoraria from Boehringer Ingelheim, Chema Rzeszow, Eli Lilly, LEO Pharma, Novartis, Sandoz, and Takeda. Adam Reich is an Editorial Board member of Dermatology and Therapy and he was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Luiza Marek-J\u00f3zefowicz, Piotr Krajewski, Julia Nowowiejska, Aleksandra Siekierko, Ewa Duchnik, Katarzyna J\u00f3\u017awicka, Magdalena Kiedrowicz, Mateusz Mleczko, Hubert Arasiewicz, Monika Kucharczyk, Witold Owczarek, Iwona Flisiak, Mariola Marchlewicz, and Beata Kr\u0119cisz declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and the ethical and institutional regulations of each participating center. Due to retrospective nature of the study, according to Polish law ethical approval was not required. Upon collection, all data were anonymized prior to any further analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}